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Abstract 
Background: To investigate the regulatory mechanism of local lymphatic 
reconstruction after cupping therapy in a mouse model.  
Materials and methods: The lymphatic reconstruction process in the mouse tail after 
cupping therapy as well as the expression levels of the vascular endothelial 
identification molecule CD34, prospero homeobox protein 1 (PROX1), and lymphatic 
vessel endothelial hyaluronan receptor 1 (LYVE-1) were investigated for a duration 
of 4 days through immunohistochemistry experiments. 
Results: On day 1 after cupping therapy, the CD34+ and LYVE-1+ cell densities were 
significantly increased, and the formed CD34+LYVE-1+ tubular structure started to 
express PROX1. This was followed by a decrease in both the CD34+ and LYVE-1+ 
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stem cell densities to basal levels on the second day after cupping therapy. Both the 
CD34+ and LYVE-1+ cell densities subsequently increased again on the third day after 
cupping therapy. The increase in the LYVE-1+ density was accompanied by tubular 
structure formation, which is characteristic of lymphangiogenesis. In addition, the 
colocalization of CD34+ and LYVE-1+ cells by immunohistochemistry suggests that 
the CD34+ stem cells differentiated into new lymphatic endothelial cells.  
Conclusions: Our findings indicate that the mechanism underlying the therapeutic 
effect of cupping therapy involves upregulation of vascular and lymphatic endothelial 
markers (CD34+, LYVE-1+, and CD34+LYVE-1+) in local tissues, which in turn 
promotes local new lymphatic vessel formation through the expression of PROX1. 
Key words: Cupping; lymphatic regeneration; mice; LYVE-1; PROX1; CD34 
 
 
INTRODUCTION 
The lymphatic system was first discovered in 1627 by Gasparo Aselli [31]. 
Compared to the vasculature, the lymphatic system is an open system. The lymph 
from the peripheral lymphatic vessels in this system enters the lymph nodes, 
lymphatic trunks, and thoracic ducts [21], and the surrounding lymphatic vessel wall 
is connected to the surrounding tissue through filaments, a layer of overlapping 
endothelial cells. Due to the lack of a continuous basement membrane and tight 
junctions [3, 10, 15], filaments are the primary means of stabilization of the lymphatic 
vessel [11]. Under physiological conditions, most lymphatic vessels are collapsed. 
However, when the interstitial pressure increases, the filament “pulls” the lymphatic 
capillaries to ensure patency, promote drainage, and increase the lumen volume. The 
formation of new lymphatic vessels is an extremely important link between 
inflammation and the repair of damaged tissues [19]. 
Cupping therapy is a traditional form of alternative medicine for the prevention, 
treatment, and control of various diseases. It involves the application of suction 
through the adherence of glass or plastic cups to the skin. This therapy is believed to 
remove toxins, purge excess body heat, promote blood circulation, relieve swelling 
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and pain, dispel coldness, and activate the meridians, among other effects. Despite the 
gradual recognition and acceptance of cupping therapy, the physiological mechanism 
of how this therapy works is not yet clearly understood. Thus, this limits its 
widespread application. Clarification of the cupping mechanism is important not only 
for the development of the therapy itself, but also for the modernization, 
standardization, and globalization of traditional Chinese medicine. At present, the 
known therapeutic effects of cupping therapy include the purging of pus that had 
formed due to bacterial infection [4, 24, 27, 28] or a snake bite [32], stretching of 
muscles to increase the pain threshold [22], relieving fatigue [5], promoting blood 
circulation [8, 17], accelerating metabolism [12, 29, 30], modulating immune function 
[18], enhancing self-resistance [26], improving immunity [33], stimulating the nerves, 
and improving the general condition of the body [23, 25, 34]. The therapeutic effect 
primarily stems from the specific structural changes of the tissues as a result of the 
suction applied during cupping therapy. The application of a stimulus intensity of 
-0.04 MPa for 10 min during cupping has been reported to cause rupture of the 
capillaries and lead to ecchymosis [1]. The greater the suction force, the greater the 
rupture, and the deeper the color of the skin that had been cupped. 
The morphological changes of the local lymph vessels after therapy and the 
mechanisms regulating the cupping process have not yet been elucidated. Therefore, 
the aim of this study was to investigate the expression profiles of the vascular 
endothelial identification molecule CD34, lymphatic vessel endothelial hyaluronan 
receptor 1 (LYVE-1), and its important regulatory molecule prospero homeobox 
protein 1 (PROX1) in the mouse tail after cupping therapy through 
immunohistochemistry experiments. The findings of this study will provide a 
theoretical basis for clinical treatment and lay the foundation for further related 
research. 
 
MATERIALS AND METHODS  
Materials 
Specific pathogen-free Kunming mice, both males and female, weighing 18–26 g, 
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were provided by the Experimental Animal Center of Shandong University (Permit 
No.: SCXK (Lu) 20090001; Experimental animal license number: SYXK (Lu) 
20100011). The goat anti-mouse LYVE-1 primary antibody was purchased from 
R&D Systems (Minneapolis, MN, USA). The donkey anti-rabbit and donkey 
anti-goat fluorescent secondary antibodies were purchased from Antgene Co. (Wuhan, 
China). The rabbit anti-mouse CD34 and rabbit anti-mouse PROX-1 primary 
antibodies, 0.01 M phosphate-buffered saline (pH 6.0), and the 3,3'-diaminobenzidine 
(DAB) immunostaining kit were purchased from Boster Biological Technology Co. 
(Wuhan, China). A DP-72 fluorescence microscope (Olympus, Japan) was used for 
the immunohistochemistry experiments. 
 
Methods 
Preparation of the mouse tail cupping model 
Twenty 8-week-old mice, regardless of gender, were randomly divided into 
groups of four each: one control and four experimental groups (days 1, 2, 3, and 4 
after negative-pressure application). After the mice in the experimental groups were 
anesthetized (50 mg/kg ketamine and 40 mg/kg benzylthiazine), all the mouse tails 
were placed in a vacuum suction device (7E-A) with negative-pressure application of 
0.4 MPa for 15 min (to simulate cupping therapy), followed by the release of negative 
pressure. The tails of the control mice were placed in the same vacuum suction device 
without negative-pressure application. Handling of the experimental animals and the 
related manipulations were performed in accordance with the guidelines of the Ethics 
Committee of the Experimental Center of Shandong University of Traditional Chinese 
Medicine. 
 
Immunohistochemistry 
Hematoxylin and eosin (H&E) staining 
At 1 to 4 days after cupping therapy, a 4-μm tail section from one mouse from 
each experimental group was prepared through conventional fixation with 40 g/L 
formaldehyde, followed by decalcification with EDTA and paraffin embedding. H&E 
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staining was then performed to observe the expression patterns of LYVE-1, CD34, 
and PROX1 in the tissue sections of the mouse tail using a DP-72 fluorescence 
microscope (Olympus, Japan). 
 
Double fluorescence staining 
Tissue sections were deparaffinized and immunostained. After inactivating 
endogenous peroxidase with 0.3% (v/v) hydrogen peroxide solution, the tissue 
sections were incubated with primary antibodies against PROX1 (rabbit anti-mouse 
antibody; 1:200), CD34 (1:100), and LYVE-1 (goat anti-mouse antibody; 1:100; 
Boster Co., Wuhan, China) at 4 °C for 24 h. This was followed by incubation with the 
secondary antibody horseradish peroxidase-labeled goat anti-rabbit IgG or rabbit 
anti-goat IgG (Boster Co., Wuhan, China), before adding the DAB substrate (Wuhan, 
China) for visualization with a DP-72 light microscope. Each slice was imaged 50 
times at 400× magnification. Semi-quantitative analysis was performed using 
Image-Pro Plus 6.0 software, and the average area was calculated. Next, the 
immunofluorescence-stained tissue sections were subjected to another round of 
immunostaining through incubation with rabbit anti-mouse PROX1 (1:100) and goat 
anti-mouse LYVE-1 (1:100) primary antibodies, followed by the simultaneous 
addition of rabbit anti-mouse CD34 (1:100) and goat anti-mouse LYVE-1 (1:100) at 
4 °C for 24 h. Subsequent incubation with either Cy3-labeled donkey anti-goat IgG or 
FITC-labeled donkey anti-rabbit IgG secondary antibodies was performed, and the 
sections were visualized using a DP-72 fluorescence microscope (Olympus, Japan). 
 
Statistical analysis 
Statistical analysis was performed using SPSS version 16.0 (Chicago, IL, USA), 
and Microsoft Excel was used for data presentation. Data from four mouse tails in 
each group were expressed as the mean ± standard deviation (SD). Comparison 
between two groups was performed using the T-test, and comparisons among three or 
more groups were performed using one-way analysis of variance followed by Fisher’s 
least significant difference test. A p value < 0.05 was considered statistically 
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significant. 
 
RESULTS 
Negative pressure application does not affect subcutaneous tissue integrity 
The subcutaneous structure of loose connective tissue in the control group 
appeared well-defined with a regular distribution of the arteries, veins, nerves, loose 
fibers, normal axons, and adventitial spaces (Fig. 1A). H&E staining revealed that 
there was no significant change in the number of blood vessels or nerves in the 
subcutaneous tissue of the mouse tail at 1 to 4 days after negative-pressure application 
(Fig. 1B–E; p>0.05). After cupping, the body mass, tail temperature, and blood flow 
returned to normal levels (p>0.05).  
 
Effect of cupping therapy on the cellular distribution of LYVE-1+ and CD34+ 
The vascular endothelial cell marker molecule CD34+ and LYVE-1+, which are 
characteristic of blood vessels and lymphatic vessels, respectively, regulate the 
regeneration of lymphatic endothelial cells. The CD34+ marker can be observed in 
vascular endothelial cells as well as in hematopoietic stem cells. We observed CD34+ 
(red) and LYVE-1+ (green) tubular structures in the perivasculature of subcutaneous, 
epimyocardial, and tubular tissues in the control group (Fig. 2A). At 1 day after 
cupping therapy, the numbers of CD34+ and LYVE-1+ cells were significantly 
increased (Fig. 3), showing a spot-like distribution (Fig. 2B). However, at 2 days after 
cupping therapy, the average areas of both LYVE-1+ (Fig. 3A) and CD34+ (Fig. 3B) 
cells decreased to basal levels comparable with that of the control group. This was 
followed by an increase in their average areas on day 3 after cupping treatment, 
wherein an approximately 2-fold increase in the LYVE-1+ density was observed (Fig. 
3A; p≤0.05), and the cells formed a tubular structure with an expanded lumen. Unlike 
the high LYVE-1+ density on day 4 after cupping treatment, the CD34+ density 
dropped back to basal levels (Fig. 3B).  
 
Cupping promotes LYVE-1 and PROX1 expression 
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Next, the expression of another lymphatic endothelial cell marker, PROX1, was 
investigated. LYVE-1 (green) and PROX1 (red) were observed to colocalize in the 
lymphatic vessels (yellow) at 1 day after cupping therapy (Fig. 4). This result suggests 
that cupping promotes lymphangiogenesis. Similarly, LYVE-1 was observed to 
colocalize (yellow) with CD34 (red) at 1 day after cupping therapy (Fig. 5). 
CD34+LYVE-1+ expression can function as a hematopoietic stem cell marker of blood 
vessels and as an intermediate-stage stem cell marker during the differentiation of 
lymphatic endothelial cells [9, 14]. Taken together, these findings indicate that 
cupping induces CD34+LYVE-1+ stem cells to initiate lymphangiogenesis. 
 
DISCUSSION 
A literature search performed before conducting this study yielded no relevant 
reports of cupping research using animal models. Hence, we designed this study to 
examine the morphological effects of cupping treatment in the mouse tail. We used a 
negative-pressure cupping device to apply a negative pressure of 0.04 MPa for 15 min 
to simulate cupping. The expression of CD34, a marker of endothelial progenitor cells 
and newborn capillary endothelial cells [13, 16]; LYVE-1, a lymphatic endothelial 
cell-specific marker [2, 7]; and PROX1, a marker for the differentiation of endothelial 
progenitor cells into lymphatic endothelial cells [6, 20]; were examined in this study 
using immunohistochemistry to investigate the reconstruction of blood vessels and 
lymphatic vessels after the cupping treatment. Of note, we observed an increased 
CD34+ cell density but not angiogenesis. In contrast, tubular structure formation 
(lymphatic vessel) and a 2-fold increase in the number of LYVE-1+ cells were 
observed after cupping therapy. Thus, we conclude that there is obvious 
lymphangiogenesis but not new blood vessel formation after cupping therapy and that 
an increased number of CD34+ cells induces differentiation into lymphatic endothelial 
cells.  
The number of CD34+ and LYVE-1+ cells in the local tissue increased 
significantly at 1 day after the cupping treatment due to the formation of a 
CD34+LYVE-1+ tubular structure. In addition, PROX1 expression was observed in 
the lymphatic endothelial cells at 1 day after cupping therapy. The decrease in the 
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number of LYVE-1+ cells at 2 days after cupping therapy is likely because of 
lymphatic vessel rupture, which causes LYVE-1+ necrosis. Since lymphatic vessels 
have thinner walls than arteries and veins, they are more susceptible to rupture under 
the same negative-pressure stimulus. The increase in LYVE-1+ cells due to the 
formation of new lymphatic vessels at 3 and 4 days after cupping therapy suggests 
that lymphatic reconstruction is an active process. A similar trend was observed for 
the CD34+ cells during the first 3 days after cupping therapy, wherein an initial 
increase in the average area of CD34+ cells was noted on day 1 after cupping 
treatment. However, on day 2 after cupping, the CD34+ cell density decreased to basal 
levels, indicating that no new blood vessels had formed. This finding suggests that 
CD34+ cells are probably sensitive to negative-pressure stimulation. Unlike LYVE-1+ 
cells, the average CD34+ density did not significantly increase on days 3 and 4 after 
cupping therapy, suggesting that blood capillaries are sufficiently strong to withstand 
negative-pressure stimulation so neovascularization was not obvious. 
Three important conclusions can be drawn from this experiment. Firstly, cupping 
therapy involving controlled negative-pressure application can increase the number of 
local vascular endothelial stem cells (CD34+) and lymphatic endothelial stem cells 
(LYVE-1+). Secondly, PROX1, a key gene for the regeneration of lymphatic 
endothelial cells, can be activated to regulate the reconstruction of local lymphatic 
vessels. Lastly, the upregulation of PROX1, LYVE-1, and CD34 does not lead to 
significant neovascularization but leads to lymphangiogenesis instead. Therefore, we 
speculate that the mechanism of cupping may be achieved by first activating the 
pluripotent stem cells in the local tissues, followed by reconstruction of the local 
lymphatic network instead of the neovascular network to repair damaged tissue cells, 
thereby increasing tissue renewal. Moreover, we demonstrated for the first time that 
the mouse tail can be used to study the mechanism of cupping. The ease of handling 
of mice and the good reproducibility of the results from our study support the use of 
mice as a good animal model for future related research. 
The limitations of cupping therapy research include the challenge in performing 
operations on fur-covered animals, the lack of suitable animal models, and the 
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difficulty in controlling the suction force applied during cupping therapy, among 
others. Only one negative-pressure value (0.04 MPa) and fixed duration of pressure 
application (15 min) was tested in this study. Since blood vessels have a higher 
pressure tolerance than lymphatic vessels, using a higher negative-pressure stimulus 
can cause blood vessel rupture and thereby stimulate angiogenesis. In the future, the 
focus should be on elucidating the effect of varying the amount of negative pressure 
applied and the duration of the pressure application. Also, the signal transduction 
pathway for negative pressure should be further investigated. Our findings propose 
lymphangiogenesis-induced blood recirculation as the underlying mechanism of the 
therapeutic effect of cupping, thus providing greater support for its clinical application 
in pain relief. 
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FIGURE LEGENDS 
Figure 1. H&E staining of mouse tails for the (A) control group and (B–E) the 
experimental groups at 1–4 days after cupping therapy, respectively, at 400× 
magnification. Compared with the control group, there was no significant change in 
the morphology or the number of blood vessels (→) or nerves (  ) in the 
subcutaneous tissue of mouse tails after cupping therapy. 
 
Figure 2. Double fluorescence staining images showing the expression of LYVE-1 
(green) and CD34 (red) in mouse tails in (A) the control group and (B–E) the 
experimental groups at 1–4 days after cupping therapy, respectively. Compared with 
the control group, the numbers of CD34+ and LYVE-1+ cells increased significantly 
(B) at 1 day after cupping therapy. (C–E) During the next 2 to 4 days, the number of 
CD34+ vessels gradually decreased, and the number of LYVE-1+ lymphatic vessels 
continued to increase. 
 
Figure 3. Plots showing the effect on the average cell densities of (A) LYVE-1+ and 
(B) CD34+ in the mouse tail after cupping therapy. * denotes p ≤ 0.05. 
 
Figure 4. Double fluorescence staining images at 400× magnification showing the 
expression of (A) LYVE-1 (green; spot-like structures), (B) PROX1 (red; observed as 
tubular structures), and (C) their merged images (yellow indicates differentiation into 
new lymphatic endothelial cells) in a mouse tail at 1 day after cupping therapy.  
 
Figure 5. Double fluorescence staining images (400× magnification) showing the 
expression of (A) LYVE-1 (green), (B) CD34 (red), and (C) their merged (yellow) 
images of the rear portion of a mouse tail at 1 day after cupping therapy. 
LYVE-1+CD34+ tubular structures appear more obvious after cupping treatment. 
 
 





